Thomas R Cannell insider trades: Sesen Bio (SESN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | SESN | ↓ Sell | 487,487 | $0.59 | $286K | Direct | Mar 6, 2023 (4d) |
| Feb 21, 2023 | SESN | ↓ Sell | 53,727 | $0.59 | $32K | Direct | Feb 23, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas R Cannell's insider trades
Thomas R Cannell is President and CEO at Sesen Bio (SESN). Since Feb 21, 2023, Thomas has reported no open-market purchases and 2 sales worth $318K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SESN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.